 SAN CARLOS, Calif., Jan. 12, 2021 PRNewswire -- Natera, Inc. NASDAQ: NTRA, a pioneer and global leader in cell-free DNA testing, today announced it will present new data on its personalized and tumor-informed molecular residual disease MRD test, Signatera, at the American Society of... 